Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacology Studies
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Effects of blood conservation and donor characteristics on transfused patient outcomes in a large community hospital network
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function
Metnase, PIKK, and RPA Roles in DNA Damage and Replication Stress Responses
Administrative Core
Eastern Cooperative Oncology Group
Recently added grants:
Spatial and Temporal Correlates of Specific Cause Mortality
Reconstitution and biophysical study of chromosome segregation machinery
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome
Development of Rac-Targeted Therapeutic Strategy for Treatment of Calcific Atherosclerosis
Mitochondrial fusion protein MFN2 prevents platelet death and dysfunction
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52204-11-0-1
Application #
7584876
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacology Studies of Antitumor &Other Therapeutic Agents
/ University of Texas MD Anderson Cancer Center
$308,593
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Newman, Robert /
$414,826
NIH 2007
N01 CA
Preclinical Pharmacology Studies
/
Comments
Be the first to comment on this grant